GB1361068A - Process for preparing injectable fluorocarbon emulsion capable of carrying oxygen - Google Patents

Process for preparing injectable fluorocarbon emulsion capable of carrying oxygen

Info

Publication number
GB1361068A
GB1361068A GB4153271A GB4153271A GB1361068A GB 1361068 A GB1361068 A GB 1361068A GB 4153271 A GB4153271 A GB 4153271A GB 4153271 A GB4153271 A GB 4153271A GB 1361068 A GB1361068 A GB 1361068A
Authority
GB
United Kingdom
Prior art keywords
emulsion
oxygen
sodium
sept
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4153271A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7802370A external-priority patent/JPS4829122B1/ja
Priority claimed from JP5700371A external-priority patent/JPS496101B1/ja
Application filed by Tanabe Seiyaku Co Ltd, Green Cross Corp Korea filed Critical Tanabe Seiyaku Co Ltd
Publication of GB1361068A publication Critical patent/GB1361068A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/14—Derivatives of phosphoric acid
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/42—Ethers, e.g. polyglycol ethers of alcohols or phenols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB4153271A 1970-09-05 1971-09-06 Process for preparing injectable fluorocarbon emulsion capable of carrying oxygen Expired GB1361068A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7802370A JPS4829122B1 (en:Method) 1970-09-05 1970-09-05
JP5700371A JPS496101B1 (en:Method) 1971-07-29 1971-07-29

Publications (1)

Publication Number Publication Date
GB1361068A true GB1361068A (en) 1974-07-24

Family

ID=26398012

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4153271A Expired GB1361068A (en) 1970-09-05 1971-09-06 Process for preparing injectable fluorocarbon emulsion capable of carrying oxygen

Country Status (5)

Country Link
CA (1) CA947653A (en:Method)
CH (1) CH604490A5 (en:Method)
DE (1) DE2144094C3 (en:Method)
FR (1) FR2105287B1 (en:Method)
GB (1) GB1361068A (en:Method)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2124104A (en) * 1982-07-27 1984-02-15 Univ Pennsylvania Perfluorochemical emulsion artificial blood
EP0307087B1 (en) * 1987-08-05 1994-06-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions for in vivo use
EP1684716A4 (en) * 2003-11-05 2009-04-22 Univ Australian DISPERSIONS AND MANUFACTURING METHOD THEREFOR

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US3993581A (en) * 1973-10-05 1976-11-23 The Green Cross Corporation Process for preparing stable oxygen transferable emulsion
JPS5331209B2 (en:Method) * 1973-10-05 1978-09-01
DK155867C (da) * 1974-12-09 1989-10-09 Sun Ventures Inc Emulsionspraeparat af perfluorerede forbindelser til anvendelse som syntetisk blod
IT1050731B (it) * 1974-12-09 1981-03-20 Childrens Hosp Medical Center Composti perfluoropoliciclici per l impiego come sangue sintetico e ambiente di ferfusione
JPS5835485B2 (ja) * 1976-02-03 1983-08-03 株式会社ミドリ十字 酸素運搬輸液
FR2515198A1 (fr) * 1981-10-22 1983-04-29 Centre Nat Rech Scient Microemulsions aqueuses de fluorocarbures indefiniment stables a une temperature donnee, procede d'obtention et application a titre de transporteurs d'oxygene
US4569784A (en) * 1980-11-17 1986-02-11 Adamantech, Inc. Preparation of a gel having gas transporting capability
US4397870A (en) * 1982-07-27 1983-08-09 The University Of Pennsylvania Process for prolonging retention of emulsion particles in the bloodstream
JPS5946218A (ja) * 1982-09-09 1984-03-15 Green Cross Corp:The フルオロカ−ボン乳化製剤
DE102021210821A1 (de) 2021-09-28 2023-03-30 Siemens Aktiengesellschaft Schutzschaltgerät

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2124104A (en) * 1982-07-27 1984-02-15 Univ Pennsylvania Perfluorochemical emulsion artificial blood
EP0307087B1 (en) * 1987-08-05 1994-06-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions for in vivo use
EP1684716A4 (en) * 2003-11-05 2009-04-22 Univ Australian DISPERSIONS AND MANUFACTURING METHOD THEREFOR

Also Published As

Publication number Publication date
FR2105287B1 (en:Method) 1975-04-18
FR2105287A1 (en:Method) 1972-04-28
DE2144094B2 (de) 1980-02-14
DE2144094C3 (de) 1980-10-09
CH604490A5 (en:Method) 1978-09-15
CA947653A (en) 1974-05-21
DE2144094A1 (de) 1972-03-09

Similar Documents

Publication Publication Date Title
GB1361068A (en) Process for preparing injectable fluorocarbon emulsion capable of carrying oxygen
SE7400989L (en:Method)
KR880701072A (ko) 혈장을 함유하지 않는 수혈가능한 혈소판 저장 합성 매질
GB1536560A (en) Stable blood plasma process for preparing it and its use as comparative plasma in coagulation tests
GB1549038A (en) Fluorocarbon emulsions capable of carrying oxygen
GB1417003A (en) Stabilisation of fibrinogen
MX157054A (es) Procedimiento para preparar derivados de disenzoxazepina
US3795581A (en) Method of maintaining or restoring the 2,3-diphosphoglycerate content of human red cells
ULLAL et al. Changes in cardiac lymph of dogs during and after anoxia
GB1362845A (en) Benzyl alcohol derivatives
US3597456A (en) Method for preparing sterile lecithin
US1609960A (en) Solution of arsenobenzene derivatives
Spitzer et al. Non-esterified fatty acid (FFA) metabolism following severe hemorrhage in the conscious dog
GB1313164A (en) Blood plasma substitute
GB899656A (en) Method for producing sterile vitamin d solutions containing calcium salts
ES399589A1 (es) Procedimiento para la fabricacion de un compuesto acido de disolucion diferida.
RU94032143A (ru) Композиция, содержащая препарат коагуляционного фактора viii, способ ее получения и применение поверхностно-активного вещества в качестве стабилизатора
DeGOWIN et al. Studies on preserved human blood: III. Toxicity of blood with high plasma potassium transfused into human beings
Andres et al. Metabolic exchange of human muscle in situ
Leinfelder Aerobic glycolysis of corneal tissue
SU608749A1 (ru) Ходова часть грузоподъемного крана
SU611613A1 (ru) Способ устранени трихиаза
Culpepper et al. Successful orthotopic allotransplantation of hearts from dogs in irreversible shock
SU136852A1 (ru) Способ получени инъекционных растворов индигокармина
SU362075A1 (ru) Раствор для фосфатирования магниевых сплавов

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years